Insulet Corporation Q3 2025 Earnings Recap

Insulet Corporation delivered a remarkable third quarter in 2025, achieving over $700 million in revenue, reflecting a 28% year-over-year growth, driven by strong customer retention and expansion in both Type 1 and Type 2 markets.

Key Takeaways

• Surpassed $700 million in quarterly revenue for the first time, demonstrating the strength of its recurring revenue model.
• Operating margins increased by 90 basis points to 17.1%, reflecting efficient cost management alongside investments in innovation.
• New customer starts in the U.S. Type 2 market more than doubled year-over-year, highlighting strong momentum and effective outreach strategies.
• International revenue grew 40% year-over-year, driven by successful global launches, including Omnipod 5, and strong demand in established markets.
• The expanded leadership team aims to further enhance Insulet's market position and customer experience across various segments.